Gyrus Capital Leads $68M Equity Investment in Neo Medical
September 17, 2024
Swiss private equity firm Gyrus Capital led a strategic equity investment of up to $68 million (CHF 58 million) into Swiss medical-technology company Neo Medical SA, with participation from existing investors including Swisscom Ventures, Verve Ventures, 4FO and Credit Suisse Entrepreneur Capital as well as the founders. The financing will fund Neo Medical’s US expansion, deployment of new spine surgery products, and further development of its AI-driven augmented reality intraoperative platform ADVISE.
- Buyers
- Gyrus Capital SA, Swisscom Ventures, Verve Ventures, 4FO (4FO Ventures), Credit Suisse Entrepreneur Capital, Vincent Lefauconnier, Jonas Larsson
- Targets
- Neo Medical SA
- Industry
- Medical Devices
- Location
- Vaud, Switzerland
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Trinity Capital Commits $35 Million Growth Capital to Neuros Medical to Scale Altius Pain Therapy Adoption
March 10, 2026
Healthcare Services
Trinity Capital Inc. committed $35 million in growth capital to Neuros Medical, Inc. to scale commercialization of its FDA-approved Altius Direct Electrical Nerve Stimulation System. The funding is intended to expand market access and improve financial flexibility as Neuros enters the next phase of adoption for post-amputation pain therapy.
-
Globus Medical To Acquire Nevro for $250 Million
February 15, 2025
Medical Devices
Globus Medical entered into a definitive agreement to acquire Nevro in an all-cash transaction valued at approximately $250 million (at $5.85 per share). The deal was unanimously approved by both companies’ boards and is expected to close late in the second quarter of 2025, subject to shareholder and regulatory approvals and customary closing conditions.
-
Nevro Corp. Acquires Vyrsa Technologies
November 30, 2023
Medical Devices
Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.
-
Gyrus Capital Acquires LRE Medical
August 1, 2023
Medical Devices
Gyrus Capital, a Geneva-based investment firm, has acquired LRE Medical, a Germany-headquartered maker of complex diagnostic devices and analytical instruments, from AIS Global (previously a KPS-backed business). LRE Medical (founded 1961) operates two sites in Germany with more than 250 employees; the transaction—a carve-out/buyout—closed in August 2023 and is intended to accelerate growth in point-of-care diagnostics.
-
ATL Technology Acquires Manufacturing Operations of Gyrus Medical Limited
April 24, 2023
Medical Devices
ATL Technology has acquired the manufacturing operations of Gyrus Medical Limited in Cardiff from Olympus Winter & Ibe GmbH (Olympus Surgical Technologies Europe). The deal expands ATL's European manufacturing footprint and engineering capabilities to support medical device OEM customers.
-
Gyrus Capital Acquires 40% Stake in Consulcesi Group
December 1, 2022
Healthcare Services
Funds advised by Gyrus Capital have acquired a 40% stake in Consulcesi Group, with founder Massimo Tortorella and management remaining involved. The investment will support Consulcesi's international expansion and M&A-driven growth to build a pan‑European digital healthcare platform and target doubling revenue to over €120 million by 2025.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.